DOYLE WILLIAM F 4

Accession 0001645113-21-000056

CIK 0001645113other

View on SEC.gov Company Profile

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 6:29 PM ET

Size

44.9 KB

Accession

0001645113-21-000056

Insider Transaction Report

Form 4

Period: 2021-04-13

NovoCure LtdNVCR

DOYLE WILLIAM F

Director10% Owner

Transactions

Sale
Ordinary Shares
2021-04-13$210.18/sh−521$109,504→ 558,593 total
Sale
Ordinary Shares
2021-04-13$196.07/sh−8,814$1,728,187→ 634,589 total
Sale
Ordinary Shares
2021-04-13$213.35/sh−1,500$320,021→ 556,493 total
Sale
Ordinary Shares
2021-04-13$214.66/sh−500$107,333→ 555,993 total
Sale
Ordinary Shares
2021-04-13$192.52/sh−1,900$365,796→ 647,093 total
Sale
Ordinary Shares
2021-04-13$194.94/sh−1,600$311,904→ 643,403 total
Sale
Ordinary Shares
2021-04-13$193.57/sh−2,090$404,563→ 645,003 total
Sale
Ordinary Shares
2021-04-13$198.98/sh−10,563$2,101,794→ 586,076 total
Sale
Ordinary Shares
2021-04-13$201.55/sh−4,125$831,377→ 577,613 total
Sale
Ordinary Shares
2021-04-13$203.25/sh−2,555$519,311→ 570,670 total
Sale
Ordinary Shares
2021-04-13$204.28/sh−1,972$402,834→ 568,698 total
Sale
Ordinary Shares
2021-04-13$209.34/sh−2,200$460,555→ 559,114 total
Sale
Ordinary Shares
2021-04-13$197.83/sh−13,612$2,692,876→ 596,639 total
Sale
Ordinary Shares
2021-04-13$206.35/sh−1,284$264,956→ 565,814 total
Sale
Ordinary Shares
2021-04-13$207.80/sh−4,500$935,118→ 561,314 total
Sale
Ordinary Shares
2021-04-13$211.28/sh−600$126,766→ 557,993 total
Sale
Ordinary Shares
2021-04-13$216.69/sh−600$130,016→ 555,393 total
Sale
Ordinary Shares
2021-04-13$191.26/sh−1,400$267,768→ 648,993 total
Sale
Ordinary Shares
2021-04-13$197.00/sh−24,338$4,794,659→ 610,251 total
Sale
Ordinary Shares
2021-04-13$199.71/sh−4,338$866,355→ 581,738 total
Sale
Ordinary Shares
2021-04-13$202.16/sh−4,388$887,069→ 573,225 total
Sale
Ordinary Shares
2021-04-13$205.43/sh−1,600$328,690→ 567,098 total

Footnotes (22)

[F1]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,400 shares in multiple trades at prices ranging from $191.00 to $191.95. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F10]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 4,125 shares in multiple trades at prices ranging from $200.85 to $201.84. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F11]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 4,388 shares in multiple trades at prices ranging from $201.85 to $202.74. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F12]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 2,555 shares in multiple trades at prices ranging from $202.90 to $203.77. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F13]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,972 shares in multiple trades at prices ranging from $203.96 to $204.90. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F14]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,600 shares in multiple trades at prices ranging from $205.00 to $205.76. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F15]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,284 shares in multiple trades at prices ranging from $206.04 to $207.01. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F16]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 4,500 shares in multiple trades at prices ranging from $207.20 to $208.20. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F17]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 2,200 shares in multiple trades at prices ranging from $208.74 to $209.72. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F18]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 521 shares in multiple trades at prices ranging from $209.81 to $210.66. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F19]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 600 shares in multiple trades at prices ranging from $211.18 to $211.38. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F2]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,900 shares in multiple trades at prices ranging from $192.00 to $193.00. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F20]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,500 shares in multiple trades at prices ranging from $212.95 to $213.72. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F21]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 500 shares in multiple trades at prices ranging from $213.99 to $214.91. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F22]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 600 shares in multiple trades at prices ranging from $216.57 to $216.79. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F3]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 2,090 shares in multiple trades at prices ranging from $193.15 to $194.06. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F4]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,600 shares in multiple trades at prices ranging from $194.38 to $195.35. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F5]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 8,814 shares in multiple trades at prices ranging from $195.38 to $196.36. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F6]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 24,338 shares in multiple trades at prices ranging from $196.38 to $197.38. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F7]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 13,612 shares in multiple trades at prices ranging from $197.39 to $198.29. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F8]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 10,563 shares in multiple trades at prices ranging from $198.49 to $199.43. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F9]On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 4,338 shares in multiple trades at prices ranging from $199.50 to $200.30. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file

4
wf-form4_161852573844212.xmlPrimary
FORM 4

Issuer

NovoCure Ltd

CIK 0001645113

→

Entity typeother

Related Parties

filerCIK 0001194459

Filing Metadata

Form type: 4
Filed: Apr 14, 8:00 PM ET
Accepted: Apr 15, 6:29 PM ET
Size: 44.9 KB

View on SEC.gov